Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.

Protein kinase C (PKC) is a multigene family consisting of at least 11 isoforms that play key roles in growth control and tumorigenesis. To understand the roles of specific isoforms of PKC in breast cancer, we generated derivatives of the human breast cancer cell line MCF-7 that stably overexpress dominant negative mutants (REG) of PKC-alpha, -epsilon, or -zeta, which encode only the regulatory domains of the respective isoforms. When stimulated to re-enter the cell cycle after serum starvation, the MCF-7/PKC-alpha-REG cell line exhibited enhanced cell-cycle progression in comparison to the control cell line. These cells also showed increased sensitivity to growth inhibition and induction of apoptosis in response to various cytotoxic stimuli, including serum starvation, tamoxifen, and gamma-radiation. Western blot analysis indicated that the MCF-7/PKC-alpha-REG cell line displayed marked decreases in the levels of the cyclin-dependent kinase inhibitor p21CIP1 and the anti-apoptotic protein bcl-2. Similar, but less striking, effects were seen in the MCF-7/PKC-epsilon-REG cell line, and the MCF-7/PKC-zeta-REG cell line showed minimal changes, when compared to the control cells. Taken together, these results suggest that the endogenous PKC-alpha in MCF-7 cells plays a critical role in regulating cell-cycle control and apoptosis, in part through upregulating the expression of p21CIP1 and bcl-2. Therefore, inhibitors of PKC-alpha may potentiate the activity of cytotoxic agents in the therapy of breast cancer.

[1]  S. Kiley,et al.  Increased protein kinase Cδ in mammary tumor cells: relationship to transformation and metastatic progression , 1999, Oncogene.

[2]  S. Kiley,et al.  Protein Kinase C δ Involvement in Mammary Tumor Cell Metastasis , 1999 .

[3]  B. Schimmer,et al.  Inhibitory Properties of the Regulatory Domains of Human Protein Kinase Cα and Mouse Protein Kinase Cε* , 1998, The Journal of Biological Chemistry.

[4]  A Sewing,et al.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[5]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[6]  J. Reed,et al.  Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells , 1997, Breast Cancer Research and Treatment.

[7]  G. Cooper,et al.  Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase , 1997, Molecular and cellular biology.

[8]  W. El-Deiry,et al.  Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells. , 1997, Cancer research.

[9]  M. Gorospe,et al.  Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells , 1996, Molecular and cellular biology.

[10]  T. McDonnell,et al.  Cell death signal transduction and Bcl-2 function. , 1996, Biochemical Society transactions.

[11]  D. Dabbs,et al.  Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[12]  Bert Vogelstein,et al.  Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.

[13]  P. Bergman,et al.  Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C- Pseudosubstrate Peptide (*) , 1996, The Journal of Biological Chemistry.

[14]  W. Lee,et al.  Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[16]  John Calvin Reed,et al.  Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. , 1995, Cancer research.

[17]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[18]  M. Ueffing,et al.  Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts , 1995, The Journal of Biological Chemistry.

[19]  Yusuf A. Hannun,et al.  Regulation of protein kinase C and role in cancer biology , 1994, Cancer and Metastasis Reviews.

[20]  C. Borner,et al.  Suppression of mitogenic activity by stable expression of the regulatory domain of PKC beta. , 1994, Carcinogenesis.

[21]  D. Fabbro,et al.  The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. , 1993, Oncogene.

[22]  W. Kolch,et al.  Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. , 1993, The Journal of biological chemistry.

[23]  Y. Nishizuka,et al.  Protein kinase C subspecies in estrogen receptor-positive and -negative human breast cancer cell lines. , 1990, Biochemical and biophysical research communications.

[24]  I. Weinstein,et al.  Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression , 1990, Molecular and cellular biology.

[25]  J. Darbon,et al.  Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity. , 1988, Cancer research.

[26]  Mark D. Johnson,et al.  Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts , 1988, Cell.

[27]  D. Lee,et al.  High activities of protein kinases C and M in fresh human stomach and breast tumors. , 1987, Yonsei medical journal.

[28]  P. Bergman,et al.  An N-myristoylated protein kinase C-α pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate , 1997, Cancer Chemotherapy and Pharmacology.

[29]  Davidson Ne,et al.  Protein kinase C and breast cancer , 1996 .

[30]  C. Thompson,et al.  Bcl-2 and Bcl-2-related proteins in apoptosis regulation. , 1995, Current topics in microbiology and immunology.

[31]  C. Borner,et al.  Involvement of protein kinase C in the growth regulation of human breast cancer cells. , 1992, Cancer treatment and research.